Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Loyola University Of Chicago has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 examiners and 3 art units, indicating that each pending action follows a separate examination path.
BRETZ, COREY LANE is the busiest examiner, with 1 pending matter. No examiner accounts for more than one listed matter, so counsel should prepare distinct responses while checking for consistent positions across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| ALAM, DANYAL HASSAN | 1 | 66.7% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18703672 | BAG3 METHODS AND USES FOR TREATMENT OF INFLAMMATION | BRETZ, COREY LANE | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18703672 | BAG3 METHODS AND USES FOR TREATMENT OF INFLAMMATION | BRETZ, COREY LANE | 1635 | §102§103§112DP | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18341330 | CORONAVIRUSES, VACCINES COMPRISING THE SAME, AND METHODS FOR PREVENTING DISEASE | ALAM, DANYAL HASSAN | 1672 | §102§112DP | Non-Final OA | — | Pending | Jun 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLoyola University Of Chicago has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Corey Lane Bretz has the most, with 1 of Loyola University Of Chicago's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
